Nedocromil Pregnancy and Breastfeeding Warnings
Brand names: Tilade
Nedocromil Pregnancy Warnings
Nedocromil has been assigned to pregnancy category B by the FDA. Animal studies using doses of 100 mg/kg/day subcutaneously have not revealed evidence of adverse fetal outcome. There are no controlled data in human pregnancy. Nedocromil is only recommended for use during pregnancy when benefit outweighs risk.
Nedocromil Breastfeeding Warnings
There are no data on the excretion of nedocromil into human milk. The manufacturer recommends that caution be used when administering nedocromil to nursing women,
See also
References for pregnancy information
- (2001) "Product Information. Tilade (nedocromil)." Rhone Poulenc Rorer
- Mcdonald CF, Burdon JGW (1996) "Asthma in pregnancy and lactation - a position paper for the thoracic society of australia and new zealand." Med J Aust, 165, p. 485-8
- Dombrowski MP (1997) "Pharmacologic therapy of asthma during pregnancy." Obstet Gynecol Clin North Am, 24, p. 559
References for breastfeeding information
- (2001) "Product Information. Tilade (nedocromil)." Rhone Poulenc Rorer
- Mcdonald CF, Burdon JGW (1996) "Asthma in pregnancy and lactation - a position paper for the thoracic society of australia and new zealand." Med J Aust, 165, p. 485-8
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
